These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China. Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP. Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568 [Abstract] [Full Text] [Related]
25. Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western Croatia. Bubonja-Šonje M, Peruč D, Abram M, Mohar-Vitezić B. Ann Hepatol; 2024 Jan; 29(1):101156. PubMed ID: 37758118 [Abstract] [Full Text] [Related]
26. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. El Chaar M, Candotti D, Crowther RA, Allain JP. Hepatology; 2010 Nov; 52(5):1600-10. PubMed ID: 20815025 [Abstract] [Full Text] [Related]
27. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
31. Challenges in hepatitis B detection among blood donors. Allain JP, Cox L. Curr Opin Hematol; 2011 Nov; 18(6):461-6. PubMed ID: 21912252 [Abstract] [Full Text] [Related]
32. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study. Mardian Y, Yano Y, Wasityastuti W, Ratnasari N, Liang Y, Putri WA, Triyono T, Hayashi Y. Virol J; 2017 Oct 23; 14(1):201. PubMed ID: 29061159 [Abstract] [Full Text] [Related]
35. Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique. Mabunda N, Zicai AF, Ismael N, Vubil A, Mello F, Blackard JT, Lago B, Duarte V, Moraes M, Lewis L, Jani I. Mem Inst Oswaldo Cruz; 2020 Oct 23; 115():e200006. PubMed ID: 32997000 [Abstract] [Full Text] [Related]
36. Significance of HBV NAT Among HBs Antigen-Negative Blood Donors in Saudi Arabia. Alabdallat NG, Bin Dukhyil AAA. Lab Med; 2018 Oct 11; 49(4):342-346. PubMed ID: 29767761 [Abstract] [Full Text] [Related]
37. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb 11; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
38. Serological characterization of occult hepatitis B virus infection among blood donors in India. Doda V, Arora S, Kirtania T. Transfus Apher Sci; 2014 Oct 11; 51(2):162-7. PubMed ID: 25131822 [Abstract] [Full Text] [Related]
39. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs]. Aydın N, Kırdar S, Uzun N, Eyigör M, Sayan M. Mikrobiyol Bul; 2016 Oct 11; 50(4):535-543. PubMed ID: 28124958 [Abstract] [Full Text] [Related]
40. Universal infant immunization and occult hepatitis B virus infection in children and adolescents: a population-based study. Hsu HY, Chang MH, Ni YH, Chiang CL, Wu JF, Chen HL. Hepatology; 2015 Apr 11; 61(4):1183-91. PubMed ID: 25501911 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]